The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells
Basic & Clinical Pharmacology & Toxicology · 2024
DOI: 10.1111/bcpt.13943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Dylan T Marsh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmacology, School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Austral…. Hauptthemen laut MEDLINE: Cannabidiol, Neurotoxicity Syndromes, Cannabinoids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Phytocannabinoids (pCBs) have been shown to inhibit the aggregation and neurotoxicity of the neurotoxic Alzheimer's disease protein beta amyloid (Aβ). We characterized the capacity of six pCBs—cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), cannabidivarin (CBDV), cannabidiol (CBD) and Δ 9 ‐tetrahydrocannabinol (Δ 9 ‐THC)—to disrupt Aβ aggregation and protect against Aβ‐evoked neurotoxicity in PC12 cells.
Methods
Neuroprotection against lipid peroxidation and Aβ‐induced cytotoxicity was assessed using the MTT assay. Transmission electron microscopy was used to visualize pCB effects on Aβ aggregation and fluorescence microscopy, with morphometrics and principal component analysis to assess PC12 cell morphology.
Results
CBD inhibited lipid peroxidation with no significant effect on Aβ toxicity, whilst CBN, CBDV and CBG provided neuroprotection. CBC, CBG and CBN inhibited Aβ 1–42 ‐induced neurotoxicity in PC12 cells, as did Δ 9 ‐THC, CBD and CBDV. CBC, CBN and CBDV inhibited Aβ aggregation, whilst Δ 9 ‐THC reduced aggregate density. Aβ 1–42 induced morphological changes in PC12 cells, including a reduction in neuritic projections and rounded cell morphology. CBC and CBG inhibited this effect, whilst Δ 9 ‐THC, CBD and CBDV did not alter Aβ 1–42 effects on cell morphology.
Conclusions
These findings highlight the neuroprotective activity of CBC, CBG and CBN as novel pCBs associated with variable effects on Aβ‐evoked neurite damage and inhibition of amyloid β aggregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Pharmacology, School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
- Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University, Tokai National Higher Education and Research System, Nagoya, Japan.
- Institute of Nano-Life-Systems, Institutes of Innovation for Future Society, Nagoya University, Tokai National Higher Education and Research System, Nagoya, Japan.
- Institute of Glyco-core Research (IGCORE), Nagoya University, Tokai National Higher Education and Research System, Nagoya, Japan.
ORCID-Profile: Scott D Smid
Zitieren
APA
Marsh, D. T., Sugiyama, A., Imai, Y., Kato, R., & Smid, S. D. (2024). The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13943
Vancouver
Marsh DT, Sugiyama A, Imai Y, Kato R, Smid SD. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.13943
BibTeX
@article{Marsh2024,
author = {Marsh, Dylan T and Sugiyama, Ayato and Imai, Yuta and Kato, Ryuji and Smid, Scott D},
title = {The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
doi = {10.1111/bcpt.13943}
}
EUVIMED